Recent Posts
Connect with:
Monday / July 15.
Homemieditorialmivision Issue 172 October 2021

mivision Issue 172 October 2021

Tired of dwelling on COVID-19 and living in the gloom of lockdowns?

Welcome to this issue of mivision – it’s packed with some seriously fun technology that will bend your mind. Wearable technology, diagnostic technology, coloured contact lens technology, IOL technology, frame and lens dispensing technology… it’s all in the pages ahead.

We’ve also placed a strong emphasis on the lucrative presbyopic market with our fashion and lens features providing a great overview of the frames, spectacle and contact lenses available to help meet the visual requirements of this discerning demographic. Similarly, the focus of our CPD articles is on presbyopes with IOL and contact lens solutions described in detail. As we head towards the end of the CPD year, I’m sure you’ll find these two articles a great source of education to help meet your required hours. For more CPD hours (and a fascinating read), head to the ophthalmology column, this time written by Dr Maree Flaherty on the inherited multi-system disorder, Neurofibromatosis type 1.

Optometry Tasmania was fortunate to be able to host a hybrid conference in August at which Professor Nitin Verma spoke about the ocular implications of COVID-19. I know, we’ve heard more than enough about COVID-19 lately but believe me, there is some really important information in our review of Prof Verma’s presentation that I know you’ll be glad you’ve read. In the same article, you can find out about The Hobart Ophthalmic Gene Therapy Centre, Australia’s first dedicated gene therapy centre, which was instigated by Professors Alex Hewitt and Brendan Vote. It’s about to open and is ready to go with cures for a number of genetic eye diseases. I’m really looking forward to bringing you news of the Centre’s achievements as time goes by.